Document is current
Any future updates will be listed below
-
Authors
Cheng, Yuanchen
Xie, Duo
Han, Yan
Guo, Siying
Sun, Zhenxing
Jing, Linkai
Man, Weitao
Liu, Dongkang
Yang, Kaiyuan
Lei, Dan
Meng, Zhe
Zhang, Huifang
Wang, Guoqin
Wu, Weiwei
Wang, Guihuai
-
Funding
Funding for this research was provided by:
Beijing Nova Program (Z211100002121050, 20220484216)
Tsinghua University (LC201906)
- License Information
-
More Information
Article History
Received: 12 April 2023
Accepted: 18 August 2023
First Online: 11 September 2023
Declarations
:
: The protocol of the PreMaSy study has been approved by the Clinical Trial Ethics Committee of Beijing Tsinghua Changgung Hospital (approval number: 22442–4-02) on September 11, 2022. Any modifications to the protocol will be discussed by all trial investigators and sent for approval by the Ethics Committee. All participants will be asked for intentions to participate, and written informed consent will be obtained from all participants.
: This protocol does not contain any data from an individual person. The results will be reported at conferences and in peer-reviewed publications.
: The authors declare that they have no competing interests.
